Thyme Care Closes $95M Series C To Fuel Cancer Care Affordability
New financing paves the path to profitability as Thyme Care mainstreams value-based cancer care; capital injection will support the anticipated...
New financing paves the path to profitability as Thyme Care mainstreams value-based cancer care; capital injection will support the anticipated...